Atlas Trials

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

Clinical trial NCT00413790 · COMPLETED

Trial details

NCT number
NCT00413790
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Healthy
Start date
2006-11-01
Enrollment
162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.